This sterile, non-pyrogenic 30mL multi-dose vial is preserved with 0.9% (9mg/mL) Benzyl Alcohol, allowing for repeated aseptic access for up to 28 days post-puncture
Always follow facility storage protocols during multi-dose usage
Combined NNMT inhibitor treatment with reduced-calorie diet achieved 6.3 g cumulative weight loss versus 2.9 g with diet alone, and fat mass reduction was ten-fold greater with treatment (~29.3%) compared to diet switch alone (2.9%), while restoring fatty liver profiles to lean-control levels (Sampson et al., 2021)
There is a significant difference between the trace amounts of BPC-157 naturally produced in your stomach and the concentrated, systemic doses used for therapeutic repair
Their ease of use and ability to act systemically make them a convenient option for research and therapeutic purposes
Wound healing and tissue regeneration: Preclinical research has highlighted BPC-157s ability to enhance healing processes in models of acute and chronic wounds